Renal & GU
AKI by pre/intra/post-renal. CKD staging and its complications. Electrolytes by mechanism. Acid-base by systematic approach. Hematuria by glomerular vs non-glomerular.
Chief complaints
Vignettes enter through one of these doors. Each complaint lays out the full differential, marks the can't-miss diagnoses, and tells you the next right action for each.
Acute kidney injury
Pre-renal, intra-renal, post-renal. Fractional excretion of sodium and urine microscopy separate them.
AKI = rise in Cr ≥ 0.3 in 48 hr or ≥ 1.5× baseline. Pre-renal: volume depletion, HF, cirrhosis, sepsis (FeNa < 1%). Intra-renal: ATN, AIN, glomerulonephritis (FeNa > 2%). Post-renal: obstruction (bladder scan, renal US).
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Pre-renal azotemia | Volume depletion (vomiting, diarrhea, diuretics), HF, cirrhosis. BUN/Cr > 20. FeNa < 1%. | IV fluids · treat underlying cause |
| Acute tubular necrosis | Ischemic (prolonged pre-renal) or toxic (contrast, aminoglycosides, cisplatin, rhabdo). Muddy brown casts. FeNa > 2%. | Supportive · remove offending agent · dialysis if AEIOU indication |
| Acute interstitial nephritis | Drug reaction (NSAIDs, PPIs, penicillins, sulfas). Rash, fever, eosinophilia (classic triad), WBC casts, urine eosinophils. | Stop offending drug · steroids if severe |
| Rhabdomyolysis | Crush injury, prolonged immobilization, statins, seizure. CK > 5× upper limit. Tea-colored urine, dipstick positive for blood but no RBCs. | Aggressive IV fluids · urine alkalinization (controversial) · watch K |
| Post-renal obstruction | Older male with BPH, stones, malignancy. Oliguria or anuria. | Bladder scan · renal US · relieve obstruction (Foley, nephrostomy, etc.) |
| Contrast-induced nephropathy | Rise in Cr 24–72 hr after contrast. Risk: CKD, DM, volume depletion. | IV fluids pre-procedure (normal saline or isotonic bicarb) · minimize contrast |
| Rapidly progressive glomerulonephritis | Hematuria, red cell casts, rising Cr over days to weeks, hypertension. | Renal biopsy · treatment depends on cause (anti-GBM, ANCA, immune complex) |
Hematuria
Glomerular (RBC casts, dysmorphic RBCs, proteinuria) vs non-glomerular (normal RBCs, no casts).
Glomerular: GN, IgA nephropathy, Alport, thin basement membrane. Non-glomerular: stones, infection, malignancy, trauma, BPH. Painless hematuria in an older patient is bladder cancer until proven otherwise. Cystoscopy.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Bladder/urothelial cancer | Painless hematuria, older smoker, occupational exposure (aniline dyes). | CT urogram · cystoscopy |
| Renal cell carcinoma | Flank pain + hematuria + mass (classic but late triad). Paraneoplastic syndromes. | CT abdomen with contrast · nephrectomy |
| Nephrolithiasis | Severe colicky flank pain radiating to groin, hematuria. | Non-contrast CT abdomen · analgesia · medical expulsive therapy (alpha blocker) |
| IgA nephropathy | Gross hematuria within days of URI. Young patient. | Renal biopsy if persistent · ACEi for proteinuria |
| UTI / pyelonephritis | Dysuria, frequency, urgency, suprapubic pain. Pyelo: flank pain, fever. | UA · urine culture · antibiotics |
| Post-strep glomerulonephritis | Child, 2–4 wk after strep throat or impetigo. Hematuria, HTN, edema, low C3. | Supportive · usually self-limited |
Hyperkalemia
The ECG changes are the emergency, not the number. Stabilize the membrane first.
Causes: pseudo (hemolysis from the draw), renal failure, ACEi/ARB/spironolactone, cell lysis (rhabdo, tumor lysis), adrenal insufficiency, acidosis. ECG: peaked T waves → PR prolongation → QRS widening → sine wave → VF.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Life-threatening hyperkalemia (K > 6.5 or ECG changes) | Peaked T waves, widened QRS, sine wave. Renal failure, meds, cell lysis. | Calcium gluconate (stabilize membrane) → insulin + glucose, albuterol, bicarb if acidotic (shift) → furosemide, kayexalate, patiromer, dialysis (remove) |
| Renal failure | Elevated Cr, oliguria. | Treat K, dialysis if AEIOU |
| Medication-induced | ACEi, ARB, spironolactone, NSAIDs, trimethoprim. | Discontinue offending agent |
| Adrenal insufficiency | Hyperkalemia + hyponatremia + hypotension + hypoglycemia. Weight loss, fatigue, hyperpigmentation. | Random cortisol, cosyntropin stim · hydrocortisone |
| Tumor lysis syndrome | Chemotherapy for hematologic malignancy. Hyperuricemia, hyperphosphatemia, hypocalcemia, hyperkalemia, AKI. | Aggressive hydration, rasburicase or allopurinol |
| Pseudohyperkalemia | Hemolyzed sample, severe leukocytosis or thrombocytosis. | Repeat specimen properly collected |
Hyponatremia
Volume status separates the differential. Correct slowly to avoid osmotic demyelination.
Step 1: measure serum osmolality. Hypertonic (hyperglycemia, mannitol). Isotonic (pseudo, hyperlipidemia, paraproteinemia). Hypotonic: volume status. Hypovolemic: vomiting, diuretics, third-spacing. Euvolemic: SIADH, hypothyroid, adrenal insufficiency, primary polydipsia. Hypervolemic: HF, cirrhosis, nephrotic.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| SIADH | Euvolemic hyponatremia, low serum osm, inappropriately concentrated urine (uosm > 100, uNa > 40). Causes: CNS disease, lung disease, malignancy (SCLC), drugs. | Fluid restriction · treat cause · salt tabs · tolvaptan if refractory |
| Hypovolemic hyponatremia | Volume depletion signs, uNa < 20 (except diuretics). | Isotonic saline |
| Hypervolemic hyponatremia | Edema, HF/cirrhosis/nephrotic. | Salt and water restriction · treat underlying · consider tolvaptan |
| Hyperglycemic pseudohyponatremia | Glucose high. Corrected Na = measured Na + 1.6 × (glucose − 100)/100. | Treat hyperglycemia |
| Beer potomania / low solute intake | Low protein/solute intake, high fluid intake. Low urine osm. | Nutrition · solute |
| Symptomatic severe hyponatremia (Na < 120 with seizures/coma) | Altered mental status, seizures. | 3% hypertonic saline (150 mL bolus) · raise Na by 4–6 mEq/L then stop · correct < 8 mEq/L in 24 hours |
Disease deep dives
Once you've identified the likely diagnosis from the chief complaint, these pages give you the presentation, workup, management, and exam pearls in depth.
Chronic Kidney Disease
Stages, complications (anemia, CKD-MBD, acidosis, HTN, CV risk), and when to refer for dialysis/transplant.
Asymptomatic early. Late: fatigue, pruritus, nausea, anorexia, edema, pericardial friction rub, asterixis.
- eGFR staging. G1 ≥ 90, G2 60–89, G3a 45–59, G3b 30–44, G4 15–29, G5 < 15 or dialysis.
- Albuminuria. A1 < 30, A2 30–300, A3 > 300 mg/g. Both eGFR and albuminuria determine prognosis.
- Complications. CBC (anemia), Ca/Phos/PTH/vit D (CKD-MBD), bicarbonate (metabolic acidosis), lipids, glucose, BP.
- Slow progression. BP < 130/80 with ACEi or ARB (especially if proteinuria). SGLT2 inhibitor in diabetic and non-diabetic CKD. Finerenone in diabetic CKD. Low-protein diet in later stages.
- Anemia. Iron repletion first (IV if dialysis). ESA (erythropoietin) when Hb < 10 with target Hb 10–11.
- CKD-MBD. Phosphate binders (calcium acetate, sevelamer), active vitamin D (calcitriol), calcimimetics (cinacalcet). Avoid aluminum.
- Acidosis. Sodium bicarbonate when bicarb < 22.
- Renal replacement. Start dialysis when symptomatic uremia, fluid overload, refractory hyperkalemia, refractory acidosis, or eGFR < 10.
- Transplant. Best long-term outcome. Refer early (eGFR < 20).
Nephritic Syndrome
Hematuria (dysmorphic RBCs, RBC casts), HTN, edema, mild proteinuria, oliguria. The differential is by mechanism.
Cola-colored urine, peripheral edema, hypertension. Elevated Cr.
- UA + sediment. RBC casts, dysmorphic RBCs. Proteinuria usually < 3.5 g/d.
- Serologies. ANCA, anti-GBM, ASO, anti-DNase B, ANA, dsDNA, complement (C3, C4), cryoglobulins, hep B/C/HIV.
- Renal biopsy. Often needed for definitive diagnosis.
- Post-strep GN. Supportive. Self-limited in most children.
- IgA nephropathy. ACEi for proteinuria. Steroids for rapid progression.
- Anti-GBM (Goodpasture). Plasmapheresis + steroids + cyclophosphamide.
- ANCA-associated vasculitis (GPA, MPA). Steroids + rituximab or cyclophosphamide. Plasmapheresis in severe disease.
- Lupus nephritis. Steroids + mycophenolate or cyclophosphamide.
Nephrotic Syndrome
Proteinuria > 3.5 g/d, hypoalbuminemia, edema, hyperlipidemia. Primary vs secondary.
Periorbital and peripheral edema, frothy urine, fatigue. Severe: anasarca, pleural effusions, ascites.
- Urine protein. Spot urine protein/Cr ratio or 24-hour protein.
- Serologies. ANA, hep B/C, HIV, SPEP/UPEP (amyloid, myeloma), complement.
- Renal biopsy. In adults usually needed to determine subtype.
- Minimal change disease. Common in children. Steroids highly effective.
- FSGS. Common in Black patients, HIV, obesity, heroin. Steroids + cyclosporine.
- Membranous. Most common primary nephrotic in adults. Associated with solid tumors, hep B, lupus, gold, penicillamine. Anti-PLA2R. Steroids + cyclophosphamide or rituximab.
- Diabetic nephropathy. Most common cause of nephrotic-range proteinuria overall. ACEi/ARB, SGLT2 inhibitor, glycemic and BP control.
- Amyloid. Biopsy with Congo red, apple-green birefringence. Treat underlying (myeloma, inflammation).
- Supportive. ACEi/ARB (reduce proteinuria), statin, salt restriction, diuretics, anticoagulation if severe (renal vein thrombosis risk).